Unknown

Dataset Information

0

P70S6K is regulated by focal adhesion kinase and is required for Src-selective autophagy.


ABSTRACT: Here we report that focal adhesion kinase (FAK) is required for optimal signalling to the Akt-p70S6K-S6 pathway in squamous cell carcinoma (SCC) cells. Specifically, in SCCs that are genetically deficient for FAK, there is reduced phosphorylation of Akt, p70S6K and S6, and signalling to Akt-p70S6K-S6 is more sensitive to inhibition by multiple agents that suppress the pathway. By contrast, mTOR is unaffected. Indeed, pharmacological agents that inhibit the Akt-p70S6K-S6 pathway, and PDK1 that lies upstream of Akt, also impair the autophagic targeting of activated c-Src (p-Src) in FAK deficient cells. This is associated with loss of a complex between p-Src and the autophagy protein LC3, a biochemical surrogate of impaired Src-selective autophagy. In keeping with a vital role for p70S6K, inhibition by a selective inhibitor and specific siRNA also impaired Src-selective autophagy. Finally, components of the PDK1-Akt-p70S6K signalling pathway were co-located with p-Src at autophagosomes, and Src and p70S6K co-exist in the same biochemical complex. We therefore deduce that the FAK-regulated signalling module PDK1-Akt-p70S6K that controls Src's intracellular trafficking operates at Src-containing autophagosomes.

SUBMITTER: Sandilands E 

PROVIDER: S-EPMC4508348 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

p70S6K is regulated by focal adhesion kinase and is required for Src-selective autophagy.

Sandilands Emma E   Schoenherr Christina C   Frame Margaret C MC  

Cellular signalling 20150609 9


Here we report that focal adhesion kinase (FAK) is required for optimal signalling to the Akt-p70S6K-S6 pathway in squamous cell carcinoma (SCC) cells. Specifically, in SCCs that are genetically deficient for FAK, there is reduced phosphorylation of Akt, p70S6K and S6, and signalling to Akt-p70S6K-S6 is more sensitive to inhibition by multiple agents that suppress the pathway. By contrast, mTOR is unaffected. Indeed, pharmacological agents that inhibit the Akt-p70S6K-S6 pathway, and PDK1 that li  ...[more]

Similar Datasets

| S-EPMC1489135 | biostudies-literature
| S-EPMC3332079 | biostudies-literature
| S-EPMC4683442 | biostudies-literature
| S-EPMC4444405 | biostudies-literature
2013-09-17 | E-GEOD-43873 | biostudies-arrayexpress
2013-09-17 | GSE43873 | GEO
| S-EPMC5573332 | biostudies-literature
| S-EPMC7192500 | biostudies-literature
| S-EPMC2266630 | biostudies-literature
| S-EPMC4326725 | biostudies-literature